ABCureD
ABCureD helps biomedical researchers and healthcare providers speed up biomarker and drug target discovery using AI. It combines in vitro experiments with in silico AI, machine learning, text data mining, and bioinformatics to deliver diagnostic and drug discovery solutions, focusing on liquid biopsy and precision medicine. The company offers R&D services, licensing, and consulting, and its LPancreas product targets pancreatic decline. With a focus on translating lab insights into clinical decisions, ABCureD aims to scale translational biomedical research for broader adoption.
ABCureD
ABCureD helps biomedical researchers and healthcare providers speed up biomarker and drug target discovery using AI. It combines in vitro experiments with in silico AI, machine learning, text data mining, and bioinformatics to deliver diagnostic and drug discovery solutions, focusing on liquid biopsy and precision medicine. The company offers R&D services, licensing, and consulting, and its LPancreas product targets pancreatic decline. With a focus on translating lab insights into clinical decisions, ABCureD aims to scale translational biomedical research for broader adoption.